Synchronous delivery of felodipine and metoprolol tartrate using monolithic osmotic pump technology

References

• Sica DA. Fixed-dose combination antihypertensive drugs. Do they have a role in rational therapy? Drugs 1994;48:16–24.
   PubMed Web of Science ®Google Scholar
• Haria M, Plosker GL, Markham A. Felodipine/metoprolol: a review of the fixed dose controlled release formulation in the management of essential hypertension. Drugs 2000;59:141–57.
   PubMed Web of Science ®Google Scholar
• Stephan D, Gaertner S, Cordeanu EM. A critical appraisal of the guidelines from France, the UK, Europe and the USA for the management of hypertension in adults. Arch Cardiovasc Dis 2015;108:453–9.
   PubMed Web of Science ®Google Scholar
• Kumaravelrajan R, Narayanan N, Suba V, et al. Simultaneous delivery of nifedipine and metoprolol tartarate using sandwiched osmotic pump tablet system. Int J Pharm 2010;399:60–70.
   PubMed Web of Science ®Google Scholar
• Gradman AH, Basile JN, Carter BL, et al. Combination therapy in hypertension. J Am Soc Hypertens 2010;4:90–8.
   PubMed Web of Science ®Google Scholar
• Flack JM, Sica DA, Bakris G, et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension 2010;56:780–800.
   PubMed Web of Science ®Google Scholar
• Liu L, Che B. Preparation of monolithic osmotic pump system by coating the indented core tablet. Eur J Pharm Biopharm 2006;64:180–4.
   PubMed Web of Science ®Google Scholar
• Dahlöf B, Hosie J. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. Blood Press Suppl 1993;1:22–9.
   PubMedGoogle Scholar
• Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990;150:1881–4.
   PubMed Web of Science ®Google Scholar
• Gorostidi M, de la Sierra A. Combination therapy in hypertension. Adv Ther 2013;30:320–36.
   PubMed Web of Science ®Google Scholar
• Waterman KC, Goeken GS, Konagurthu S, et al. Osmotic capsules: a universal oral, controlled-release drug delivery dosage form. J Control Release 2011;152:264–9.
   PubMed Web of Science ®Google Scholar
• Qin C, He W, Zhu C, et al. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet. Int J Pharm 2014;466:276–85.
   PubMed Web of Science ®Google Scholar
• Priya MR, Rajendran NN. Simultaneous and extended delivery of stavudine, lamivudine and nevirapine in fixed dose combination using sandwiched osmotic tablets for HIV therapy. Curr Drug Deliv 2015;12:600–12.
   PubMed Web of Science ®Google Scholar
• Patel RB, Patel GN, Patel HR, et al. Inlay osmotic pump tablets containing metformin and glipizide. Drug Dev Ind Pharm 2011;37:1244–52.
   PubMed Web of Science ®Google Scholar
• Prabakaran D, Singh P, Kanaujia P, et al. Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization. Int J Pharm 2004;284:95–108.
   PubMed Web of Science ®Google Scholar
• Abrahamsson B, Edgar B, Lidman K, et al. Design and pharmacokinetics of Logimax, a new extended-release combination tablet of felodipine and metoprolol. Blood Press Suppl 1993;1:10–15.
   PubMedGoogle Scholar
• Verma RK, Mishra B, Garg S. Osmotically controlled oral drug delivery. Drug Dev Ind Pharm 2000;26:695–708.
   PubMed Web of Science ®Google Scholar
• Guan J, Zhou L, Nie S, et al. A novel gastric-resident osmotic pump tablet: in vitro and in vivo evaluation. Int J Pharm 2010;383:30–6.
   PubMed Web of Science ®Google Scholar
• Xu H, Li Z, Pan H, et al. A novel bi-layer ascending release osmotic pump tablet: in vitro investigation and in vivo investigation in pharmacokinetic study and IVIVC evaluation. Int J Pharm 2013;458:181–7.
   PubMed Web of Science ®Google Scholar
• Ketjinda W, Sinchaipanid N, Limsuwan P, et al. Development of push-pull osmotic tablets using chitosan-poly(acrylic acid) interpolymer complex as an osmopolymer. AAPS PharmSciTech 2011;12:132–40.
   PubMed Web of Science ®Google Scholar
• Yanfei M, Guoguang C, Lili R, et al. Controlled release of ziprasidone solid dispersion systems from osmotic pump tablets with enhanced bioavailability in the fasted state. Drug Dev Ind Pharm 2015;41:1353–62.
   PubMed Web of Science ®Google Scholar
• Xie Y, Lu Y, Qi J, et al. Synchronized and controlled release of multiple components in silymarin achieved by the osmotic release strategy. Int J Pharm 2013;441:111–20.
   PubMed Web of Science ®Google Scholar
• Lu C, Lu Y, Chen J, et al. Synchronized and sustained release of multiple components in silymarin from erodible glyceryl monostearate matrix system. Eur J Pharm Biopharm 2007;66:210–19.
   PubMed Web of Science ®Google Scholar
• Li S, Wang X, Wang Y, et al. A novel osmotic pump-based controlled delivery system consisting of pH-modulated solid dispersion for poorly soluble drug flurbiprofen: in vitro and in vivo evaluation. Drug Dev Ind Pharm 2015;41:2089–99.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang X. Solubility-modulated monolithic osmotic pump tablet for atenolol delivery. Eur J Pharm Biopharm 2008;68:298–302.
   PubMed Web of Science ®Google Scholar
• Ouyang D, Nie S, Li W, et al. Design and evaluation of compound metformin/glipizide elementary osmotic pump tablets. J Pharm Pharmacol 2005;57:817–20.
   PubMed Web of Science ®Google Scholar
• Defang O, Shufang N, Wei L, et al. In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide. Drug Dev Ind Pharm 2005;31:677–85.
   PubMed Web of Science ®Google Scholar
• Kim EJ, Chun MK, Jang JS, et al. Preparation of a solid dispersion of felodipine using a solvent wetting method. Eur J Pharm Biopharm 2006;64:200–5.
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Watanabe Y, Takayama K, et al. Effect of hydroxypropylmethylcellulose (HPMC) on the release profiles and bioavailability of a poorly water-soluble drug from tablets prepared using macrogol and HPMC. Int J Pharm 2000;202:173–8.
   PubMed Web of Science ®Google Scholar
• Li Z, Yu F, Di Z, et al. Development and uniform evaluation of ropinirole osmotic pump tablets with REQUIP XL both in vitro and in beagle dogs. Drug Dev Ind Pharm 2016;42:12--8.
   PubMed Web of Science ®Google Scholar
• Campos-Aldrete ME, Villafuerte-Robles L. Influence of the viscosity grade and the particle size of HPMC on metronidazole release from matrix tablets. Eur J Pharm Biopharm 1997;43:173–8.
   Web of Science ®Google Scholar
• Riekes MK, Kuminek G, Rauber GS, et al. HPMC as a potential enhancer of nimodipine biopharmaceutical properties via ball-milled solid dispersions. Carbohydr Polym 2014;99:474–82.
   PubMed Web of Science ®Google Scholar
• Conti S, Maggi L, Segale L, et al. Matrices containing NaCMC and HPMC 2. Swelling and release mechanism study. Int J Pharm 2007;333:143–51.
   PubMed Web of Science ®Google Scholar
• Michailova V, Titeva S, Kotsilkova R, et al. Water uptake and relaxation processes in mixed unlimited swelling hydrogels. Int J Pharm 2000;209:45–56.
   PubMed Web of Science ®Google Scholar
• Juárez H, Rico G, Villafuerte L. Influence of admixed carboxymethylcellulose on release of 4-aminopyridine from hydroxypropyl methylcellulose matrix tablets. Int J Pharm 2001;216:115–25.
   PubMed Web of Science ®Google Scholar
• Guo JH. Effects of plasticizers on water permeation and mechanical properties of cellulose-acetate-antiplasticization in slightly plasticized polymer film. Drug Dev Ind Pharm 2008;19:1541–55.
   Web of Science ®Google Scholar
• Rani M, Mishra B. Comparative in vitro and in vivo evaluation of matrix, osmotic matrix, and osmotic pump tablets for controlled delivery of diclofenac sodium. AAPS PharmSciTech 2004;5:153–9.
   Web of Science ®Google Scholar
• Gong W, Liu Y, Mei DY, et al. Preparation, release and pharmacokinetics of a risperidone elementary osmotic pump system. Drug Dev Ind Pharm 2014. [Epub ahead of print]. doi:10.3109/03639045.2013.877923.
   Web of Science ®Google Scholar
• Dressman JB. Comparison of canine and human gastrointestinal physiology. Pharm Res 1986;3:123–31.
   PubMed Web of Science ®Google Scholar